Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2591 stock hub

HKG/2591 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2591is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2591

In the news

Latest news · HKG/2591

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-36.9

P25 -14.7P50 2P75 9.4

ROIC-21.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2591 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

CNY

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	193
Enterprise value	HKD 4.6B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE1000071Q7
Last refreshed	2026-05-10
Market cap	HKD 5.8B
Price	HKD 12.65
Price currency	HKD
Rev Per Employee	758,261.98x
Sector	Healthcare
Sic	2836
Symbol	hkg/2591
Website	https://www.innogenpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.57%
EV Earnings	-12.17x
EV/FCF	-13.17x
EV/Sales	31.59x
FCF yield	-6.08%
P/B ratio	4.93x
P/S ratio	39.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-263.76%
EBITDA Margin	-258.32%
Gross margin	89.01%
Gross Profit	HKD 130.3M
Gross Profit Growth	131.84%
Net Income	HKD -379.9M
Net Income Growth Years	0%
Pretax Margin	-259.57%
Profit Margin	-259.57%
Profit Per Employee	HKD -2M
ROA	-17.3
ROCE	-32.53
ROE	-36.91
ROIC	-21.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.1
Assets	HKD 1.7B
Cash	HKD 1.3B
Current Assets	HKD 1.7B
Current Liabilities	HKD 581.1M
Debt	HKD 185M
Debt Equity	HKD 0.16
Debt FCF	HKD -0.53
Equity	HKD 1.2B
Interest Coverage	-202
Liabilities	HKD 576M
Long Term Assets	HKD 45.1M
Long Term Liabilities	HKD -5.1M
Net Cash	HKD 1.2B
Net Cash By Market Cap	HKD 19.99
Net Cash Growth	31.94%
Net Debt Equity	HKD -0.99
Tangible Book Value	HKD 1.1B
Tangible Book Value Per Share	HKD 2.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.93
Inventory Turnover	0.2
Net Working Capital	HKD -85.5M
Quick ratio	2.67
Working Capital	HKD 1.1B
Working Capital Turnover	HKD 0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	20.6
All Time High	74
All Time High Change	-82.91%
All Time High Date	2025-08-15
All Time Low	12.16
All Time Low Change	4.03%
All Time Low Date	2026-05-08
ATR	1.47
Beta1y	2.54
Ch YTD	-58.71
High	13.16
High52	74
High52 Date	2025-08-15
High52ch	-82.91%
Low	12.16
Low52	12.16
Low52 Date	2026-05-08
Low52ch	4.03%
Ma50ch	-38.58%
RSI	24.7
RSI Monthly	0
RSI Weekly	18.48
Sharpe ratio	-2.37x
Sortino ratio	-3.23
Total Return	-3.44%
Tr YTD	-58.71
Tr1m	-39.36%
Tr1w	-10.79%
Tr3m	-52.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -386M
Operating margin	-263.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	246,276,216%
Net Borrowing	159,433,904.5
Shares Insiders	10.12%
Shares Institutions	46.87%
Shares Out	456,819,349
Shares Qo Q	6.58%
Shares Yo Y	3.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -367.7M
Average Volume	916,939.5x
Bv Per Share	2.57
CAPEX	HKD -22.2M
Ch1m	-39.36
Ch1w	-10.79
Ch3m	-52.87
Ch6m	-57.83
Change	1.36%
Change From Open	-0.78
Close	12.48
Days Gap	2.16
Depreciation Amortization	8,248,646.1
Dollar Volume	19,210,290
Earnings Date	2026-05-13
EBIT	HKD -386M
EBITDA	HKD -378M
EPS	HKD -0.88
F Score	1
FCF	HKD -351.1M
FCF EV Yield	-7.59x
FCF Per Share	HKD -0.77
Financing CF	803,858,513
Fiscal Year End	December
Founded	2,014
Investing CF	25,180,670
Is Primary Listing	1
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Ma150	29.04
Ma150ch	-56.43%
Ma20	17.12
Ma20ch	-26.11%
Net CF	492,503,108
Next Earnings Date	2026-05-13
Open	12.75
Position In Range	49
Ppne	40,507,381.9
Price Date	2026-05-08
Ptbv Ratio	5.03
Relative Volume	1.61x
Revenue	146,344,563x
SBC By Revenue	11.37x
Share Based Comp	16,646,528
Tr6m	-57.83%
Volume	1,518,600
Z Score	17.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2591 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2591?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.9%

Share of float held by funds and institutions

Insider ownership

+10.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.4%

Negative means the company is buying back shares.

Technical

HKG/2591 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.7

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-2.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2591

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2591 stock rating?

hkg/2591 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2591 analysis?

The full report lives at /stocks/hkg/2591/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2591?

The latest report frames hkg/2591 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2591 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.